NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

5101. Use of telemedicine among office-based physicians, 2021

Author(s):
Pylypchuk, Yuriy, author
Barker, Wesley, author
Publication:
[Washington, DC] : Office of the National Coordinator for Health Information Technology, March 2023
Subject(s):
Physicians -- statistics & numerical data
Telemedicine -- statistics & numerical data
Telemedicine -- trends
Diffusion of Innovation
Electronic Health Records -- statistics & numerical data
United States

5102. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

Author(s):
Tice, Jeffrey A., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Chapman, Rick, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Mandrik, Olena, author
Thokala, P. (Praveen), author
Fotheringham, James, (Of University of Sheffield), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021
Subject(s):
Antibodies, Monoclonal, Humanized
B-Cell Activating Factor -- antagonists & inhibitors
Calcineurin Inhibitors -- therapeutic use
Cyclosporine -- therapeutic use
Immunosuppressive Agents -- therapeutic use
Lupus Nephritis -- drug therapy
Treatment Outcome
United States

5103. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):
Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):
Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

5104. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):
Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):
Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy Combination
Ezetimibe -- therapeutic use
United States

5106. Labs with questionably high billing for additional tests alongside COVID-19 tests warrant further scrutiny

Author(s):
Maxwell, Ann, (Deputy Inspector General for Evaluation and Inspections), author
Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):
Clinical Laboratory Techniques -- economics
Costs and Cost Analysis
COVID-19 Testing -- economics
Insurance, Health, Reimbursement
Medicare Part B
United States

5110. Zoonotic diseases: Federal actions needed to improve surveillance and better assess human health risks posed by wildlife : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, May 2023
Subject(s):
Government Regulation
Legislation, Medical
Sentinel Surveillance
Wildlife Trade -- legislation & jurisprudence
Zoonoses -- prevention & control
United States